Boston Scientific starts NextStent study |
|
|
|
Published
:
Thu, 31 May 2007 20:18 |
NEW YORK (AP) - Medical device maker Boston Scientific Corp. said Thursday it enrolled its first patient in a post-market approval study of its NextStent cartoid stent system.The system, approved in November, is used along with Boston Scientific's FilterWire EZ embolic protection system. The goal of the post-market approval study is to confirm the safety and effectiveness of the system. The study is designed to include 1,500 patients.Shares of Boston Scientific rose 22 cents to $15.65 in afternoon trading.Copyright 2007 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
|
|
|
|